Inactive Instrument

Highlights Surgical Science Sweden AB (publ) Nasdaq Stockholm

Equities

SE0014428512

Highlights

Unlock all the news: Be the first to know and act before the market!

Surgical Science Sweden AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-21	CI
Surgical Science Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
Surgical Science Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-16	CI
Surgical Science Sweden AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-22	CI
Surgical Science Sweden AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-22	CI
The American Society for Gastrointestinal Endoscopy and Surgical Science to Jointly Developes New Gi Endoscopic Simulation-Based Curricula	22-11-30	CI
Surgical Science Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Surgical Science Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-25	CI
Surgical Science Sweden AB Receives Order of Approximately SEK 66 Million	22-05-26	CI
Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Surgical Science Sweden AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-16	CI
Surgical Science Sweden AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-16	CI
Interim report January-September 2021: A GOOD START TO THE MERGER WITH SIMBIONIX	21-11-10	AQ
Surgical Science Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Surgical Science Sweden : Completes Acquisition Of Simbionix USA	21-08-24	MT
Surgical Science Sweden AB (OM:SUS) completed the acquisition of Simbionix USA Corporation from 3D Systems, Inc.	21-08-23	CI
Surgical Science Sweden AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-20	CI
Surgical Science Sweden AB (OM:SUS) entered into a definitive agreement to acquire Simbionix USA Corporation from 3D Systems, Inc. for approximately $310 million.	21-07-27	CI
Surgical Science Sweden AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Surgical Science Sweden AB (publ) Nasdaq Stockholm

Equities

SE0014428512

Highlights

Filters